Aasmund Reikvam

2.9k total citations
24 papers, 1.2k citations indexed

About

Aasmund Reikvam is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Aasmund Reikvam has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 8 papers in Geriatrics and Gerontology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Aasmund Reikvam's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Cardiovascular Function and Risk Factors (5 papers) and Acute Myocardial Infarction Research (5 papers). Aasmund Reikvam is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Cardiovascular Function and Risk Factors (5 papers) and Acute Myocardial Infarction Research (5 papers). Aasmund Reikvam collaborates with scholars based in Norway, United States and France. Aasmund Reikvam's co-authors include Hege Salvesen Blix, Kirsten K. Viktil, Tron Anders Moger, Kjell I. Pettersen, Hedvig Nordeng, Rolf Lindemann, Knut Stavem, Arnfinn Rollag, Halldóra Jónsdóttir and Ole A. Andreassen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Antimicrobial Chemotherapy and Acta Psychiatrica Scandinavica.

In The Last Decade

Aasmund Reikvam

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aasmund Reikvam Norway 16 599 291 260 236 224 24 1.2k
Louise Mallet Canada 16 549 0.9× 153 0.5× 187 0.7× 129 0.5× 194 0.9× 58 1.2k
Robert L. Maher United States 7 954 1.6× 291 1.0× 165 0.6× 273 1.2× 475 2.1× 13 1.4k
Peter Loewen Canada 20 368 0.6× 381 1.3× 179 0.7× 118 0.5× 174 0.8× 86 1.5k
Paul A. F. Jansen Netherlands 23 797 1.3× 272 0.9× 253 1.0× 281 1.2× 372 1.7× 57 1.7k
Sven Schmiedl Germany 13 661 1.1× 157 0.5× 290 1.1× 218 0.9× 298 1.3× 51 1.2k
John D. Barratt Australia 18 661 1.1× 252 0.9× 108 0.4× 194 0.8× 357 1.6× 34 1.3k
Debbie Rigby Australia 12 998 1.7× 198 0.7× 201 0.8× 280 1.2× 535 2.4× 50 1.4k
Ronald L. Castelino Australia 23 884 1.5× 286 1.0× 245 0.9× 457 1.9× 444 2.0× 103 1.7k
Hanna M. Seidling Germany 21 646 1.1× 139 0.5× 191 0.7× 185 0.8× 129 0.6× 102 1.2k
SL Jackson Australia 24 723 1.2× 462 1.6× 112 0.4× 226 1.0× 211 0.9× 95 1.5k

Countries citing papers authored by Aasmund Reikvam

Since Specialization
Citations

This map shows the geographic impact of Aasmund Reikvam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aasmund Reikvam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aasmund Reikvam more than expected).

Fields of papers citing papers by Aasmund Reikvam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aasmund Reikvam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aasmund Reikvam. The network helps show where Aasmund Reikvam may publish in the future.

Co-authorship network of co-authors of Aasmund Reikvam

This figure shows the co-authorship network connecting the top 25 collaborators of Aasmund Reikvam. A scholar is included among the top collaborators of Aasmund Reikvam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aasmund Reikvam. Aasmund Reikvam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Viktil, Kirsten K., et al.. (2012). How are drug regimen changes during hospitalisation handled after discharge: a cohort study. BMJ Open. 2(6). e001461–e001461. 70 indexed citations
2.
Blix, Hege Salvesen, et al.. (2012). Handling drug-related problems in rehabilitation patients: a randomized study. International Journal of Clinical Pharmacy. 34(2). 382–388. 23 indexed citations
3.
Haug, Jon Birger, et al.. (2011). Increased antibiotic use in Norwegian hospitals despite a low antibiotic resistance rate. Journal of Antimicrobial Chemotherapy. 66(11). 2643–2646. 17 indexed citations
4.
Grundtvig, Morten, et al.. (2011). Mortality after myocardial infarction: impact of gender and smoking status. European Journal of Epidemiology. 26(5). 385–393. 16 indexed citations
5.
Blix, Hege Salvesen, Kirsten K. Viktil, Tron Anders Moger, & Aasmund Reikvam. (2010). Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients. Pharmacy Practice. 8(1). 50–5. 66 indexed citations
6.
Stavem, Knut, et al.. (2008). Health-related quality of life after myocardial infarction is associated with level of left ventricular ejection fraction. SHILAP Revista de lepidopterología. 27 indexed citations
7.
Pettersen, Kjell I., Aasmund Reikvam, Arnfinn Rollag, & Knut Stavem. (2008). Understanding sex differences in health-related quality of life following myocardial infarction. International Journal of Cardiology. 130(3). 449–456. 49 indexed citations
8.
Blix, Hege Salvesen, Kirsten K. Viktil, Tron Anders Moger, & Aasmund Reikvam. (2008). Identification of drug interactions in hospitals – computerized screening vs. bedside recording. Journal of Clinical Pharmacy and Therapeutics. 33(2). 131–139. 28 indexed citations
9.
Pettersen, Kjell I., et al.. (2008). Health-related quality of life after myocardial infarction is associated with level of left ventricular ejection fraction. BMC Cardiovascular Disorders. 8(1). 28–28. 2 indexed citations
10.
Jónsdóttir, Halldóra, Svein Friis, Robert Horne, et al.. (2008). Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders. Acta Psychiatrica Scandinavica. 119(1). 78–84. 102 indexed citations
11.
Viktil, Kirsten K., Hege Salvesen Blix, Tron Anders Moger, & Aasmund Reikvam. (2006). Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug‐related problems. British Journal of Clinical Pharmacology. 63(2). 187–195. 403 indexed citations
12.
Pettersen, Kjell I., et al.. (2006). High mortality in diabetic patients with acute myocardial infarction: Cardiovascular co-morbidities contribute most to the high risk. International Journal of Cardiology. 121(2). 184–188. 23 indexed citations
13.
Viktil, Kirsten K., Hege Salvesen Blix, Tron Anders Moger, & Aasmund Reikvam. (2006). Interview of patients by pharmacists contributes significantly to the identification of drug‐related problems (DRPs). Pharmacoepidemiology and Drug Safety. 15(9). 667–674. 48 indexed citations
14.
Blix, Hege Salvesen, Kirsten K. Viktil, Tron Anders Moger, & Aasmund Reikvam. (2006). Use of renal risk drugs in hospitalized patients with impaired renal function--an underestimated problem?. Nephrology Dialysis Transplantation. 21(11). 3164–3171. 79 indexed citations
15.
Pettersen, Kjell I., Aasmund Reikvam, & Knut Stavem. (2005). Reliability and validity of the Norwegian translation of the Seattle Angina Questionnaire following myocardial infarction. Quality of Life Research. 14(3). 883–889. 9 indexed citations
16.
17.
Pettersen, Kjell I., Aasmund Reikvam, Arnfinn Rollag, & Knut Stavem. (2004). Reliability and Validity of the Kansas City Cardiomyopathy Questionnaire in Patients with Previous Myocardial Infarction. European Journal of Heart Failure. 7(2). 235–242. 45 indexed citations
18.
Reikvam, Aasmund, et al.. (2003). Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular function. Scandinavian Cardiovascular Journal. 37(3). 130–134. 1 indexed citations
19.
Landmark, Knud, Aasmund Reikvam, Michel Abdelnoor, E Sivertssen, & Ivar Aursnes. (1998). Acute Myocardial Infarction Mortality Related to Use of Calcium Antagonists Before Admission to Hospital. Cardiovascular Drugs and Therapy. 12(2). 183–187. 2 indexed citations
20.
Reikvam, Aasmund, et al.. (1993). Late cardiac manifestation of infection with Borrelia burgdorferi (Lyme disease).. BMJ. 307(6897). 173–173. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louise Mallet Breakdown of academic impact, for papers by Robert L. Maher Breakdown of academic impact, for papers by Peter Loewen Breakdown of academic impact, for papers by Paul A. F. Jansen Breakdown of academic impact, for papers by Sven Schmiedl Breakdown of academic impact, for papers by John D. Barratt Breakdown of academic impact, for papers by Debbie Rigby Breakdown of academic impact, for papers by Ronald L. Castelino Breakdown of academic impact, for papers by Hanna M. Seidling Breakdown of academic impact, for papers by SL Jackson
Rankless by CCL
2026